Correlation Between Eyenovia and Exagen
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Exagen Inc, you can compare the effects of market volatilities on Eyenovia and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Exagen.
Diversification Opportunities for Eyenovia and Exagen
Pay attention - limited upside
The 3 months correlation between Eyenovia and Exagen is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Eyenovia i.e., Eyenovia and Exagen go up and down completely randomly.
Pair Corralation between Eyenovia and Exagen
Given the investment horizon of 90 days Eyenovia is expected to under-perform the Exagen. In addition to that, Eyenovia is 1.86 times more volatile than Exagen Inc. It trades about -0.11 of its total potential returns per unit of risk. Exagen Inc is currently generating about 0.14 per unit of volatility. If you would invest 252.00 in Exagen Inc on October 7, 2024 and sell it today you would earn a total of 106.00 from holding Exagen Inc or generate 42.06% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Eyenovia vs. Exagen Inc
Performance |
Timeline |
Eyenovia |
Exagen Inc |
Eyenovia and Exagen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eyenovia and Exagen
The main advantage of trading using opposite Eyenovia and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.Eyenovia vs. Capricor Therapeutics | Eyenovia vs. Akari Therapeutics PLC | Eyenovia vs. Soleno Therapeutics | Eyenovia vs. Bio Path Holdings |
Exagen vs. Fonar | Exagen vs. Burning Rock Biotech | Exagen vs. Sera Prognostics | Exagen vs. Castle Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |